The event “Anti-HER2 therapies: biological mechanisms and toxicity management“ is a live webinar scheduled for December 4, 2025, at 18:00 CET.

This online educational session is focused on breast cancer and will feature experts who will discuss the molecular mechanisms that underpin HER2-targeted treatments and their role in improving patient outcomes, while also providing a comprehensive and practical overview of the challenges and strategies for managing therapy-related toxicities.

The webinar aims to enhance the knowledge of clinicians and researchers involved in the care of patients with HER2-positive breast cancer.